Consensus on BCR‐ABL1 reporting in chronic myeloid leukaemia in the UK

For patients with chronic myeloid leukaemia (CML), treatment guidelines recommend monitoring response to treatment with tyrosine kinase inhibitors (TKIs) by testing the BCR‐ABL1 fusion gene transcript level using reverse transcriptase quantitative polymerase chain reaction. Despite recent efforts to...

Descripción completa

Detalles Bibliográficos
Autores principales: Cross, Nicholas C. P., White, Helen E., Evans, Paul A. S., Hancock, Jeremy, Copland, Mhairi, Milojkovic, Dragana, Mason, Joanne, Craine, Sandra, Mead, Adam J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6175193/
https://www.ncbi.nlm.nih.gov/pubmed/30125955
http://dx.doi.org/10.1111/bjh.15542

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6175193/
https://www.ncbi.nlm.nih.gov/pubmed/30125955
http://dx.doi.org/10.1111/bjh.15542

Ejemplares similares